黑质
小胶质细胞
多巴胺能
神经炎症
神经科学
帕金森病
MPTP公司
医学
炎症
多巴胺
免疫学
生物
内科学
疾病
作者
Tong Shen,Guiyun Cui,Hao Chen,Long Huang,Weihong Song,Jie Zu,Wei Zhang,Chunmei Xu,Liguo Dong,Yongmei Zhang
标识
DOI:10.4103/1673-5374.385843
摘要
Abstract JOURNAL/nrgr/04.03/01300535-202406000-00043/inline-graphic1/v/2023-10-30T152229Z/r/image-tiff Microglia-mediated neuroinflammation is considered a pathological feature of Parkinson’s disease. Triggering receptor expressed on myeloid cell-1 (TREM-1) can amplify the inherent immune response, and crucially, regulate inflammation. In this study, we found marked elevation of serum soluble TREM-1 in patients with Parkinson’s disease that positively correlated with Parkinson’s disease severity and dyskinesia. In a mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease, we found that microglial TREM-1 expression also increased in the substantia nigra. Further, TREM-1 knockout alleviated dyskinesia in a mouse model of Parkinson’s disease and reduced dopaminergic neuronal injury. Meanwhile, TREM-1 knockout attenuated the neuroinflammatory response, dopaminergic neuronal injury, and neutrophil migration. Next, we established an in vitro 1-methyl-4-phenyl-pyridine-induced BV2 microglia model of Parkinson’s disease and treated the cells with the TREM-1 inhibitory peptide LP17. We found that LP17 treatment reduced apoptosis of dopaminergic neurons and neutrophil migration. Moreover, inhibition of neutrophil TREM-1 activation diminished dopaminergic neuronal apoptosis induced by lipopolysaccharide. TREM-1 can activate the downstream CARD9/NF-κB proinflammatory pathway via interaction with SYK. These findings suggest that TREM-1 may play a key role in mediating the damage to dopaminergic neurons in Parkinson’s disease by regulating the interaction between microglia and peripheral neutrophils.
科研通智能强力驱动
Strongly Powered by AbleSci AI